Dutasteride, Tadalafil & Solifenacin Tablets

Dutasteride, Tadalafil & Solifenacin Tablets

Categories : Nephrology & Urology

Product Packaging : 10 / 30 tablets

Product Composition : 0.5 mg, 10 mg & 10 mg

Dutasteride, Tadalafil & Solifenacin Tablets are an advanced triple-combination therapy designed for comprehensive management of benign prostatic hyperplasia (BPH) with associated lower urinary tract symptoms (LUTS) and overactive bladder (OAB). This synergistic formulation offers multi-mechanism action:

  • Dutasteride reduces prostate size by inhibiting 5-alpha reductase and lowering DHT levels
  • Tadalafil improves blood flow and relieves urinary symptoms while supporting erectile function
  • Solifenacin controls bladder overactivity by reducing urinary urgency and frequency

Genliva Wellness LLP is a trusted Dutasteride Tadalafil Solifenacin Tablets manufacturer in India, delivering premium-quality formulations through WHO-GMP and ISO-certified pharmaceutical manufacturing facilities. As a growing exporter and contract manufacturer, the company ensures consistent quality, regulatory compliance, and global market readiness.

With strong capabilities in pharmaceutical contract manufacturing, third-party production, and international export, Genliva Wellness LLP supplies this combination to Africa, Southeast Asia, CIS countries, Middle East, and Latin America, serving urology specialists, hospitals, and global distributors.

Send Message

Dutasteride, Tadalafil & Solifenacin Tablets are an advanced triple-combination therapy designed for comprehensive management of benign prostatic hyperplasia (BPH) with associated lower urinary tract symptoms (LUTS) and overactive bladder (OAB). This synergistic formulation offers multi-mechanism action:

  • Dutasteride reduces prostate size by inhibiting 5-alpha reductase and lowering DHT levels
  • Tadalafil improves blood flow and relieves urinary symptoms while supporting erectile function
  • Solifenacin controls bladder overactivity by reducing urinary urgency and frequency

Genliva Wellness LLP is a trusted Dutasteride Tadalafil Solifenacin Tablets manufacturer in India, delivering premium-quality formulations through WHO-GMP and ISO-certified pharmaceutical manufacturing facilities. As a growing exporter and contract manufacturer, the company ensures consistent quality, regulatory compliance, and global market readiness.

With strong capabilities in pharmaceutical contract manufacturing, third-party production, and international export, Genliva Wellness LLP supplies this combination to Africa, Southeast Asia, CIS countries, Middle East, and Latin America, serving urology specialists, hospitals, and global distributors.

  • Leading Dutasteride Tadalafil Solifenacin Tablets manufacturer in India with GMP certification
  • Reliable Dutasteride Tadalafil Solifenacin Tablets exporter for global pharmaceutical markets
  • Specialized Dutasteride Tadalafil Solifenacin Tablets contract manufacturer for third-party production
  • Triple-action formulation targeting BPH, LUTS, erectile dysfunction (ED), and OAB
  • Dutasteride for prostate size reduction and hormonal control
  • Tadalafil for improved urinary flow and erectile function support
  • Solifenacin for bladder control and reduction of urgency/frequency
  • Manufactured using high-quality APIs under strict quality assurance protocols
  • Suitable for bulk supply, institutional procurement, and long-term therapy markets
  • Available with custom packaging, private labeling, and export documentation support
  • Backed by Genliva’s reputation as a global pharmaceutical exporter from India

Dutasteride, Tadalafil & Solifenacin Tablets are widely used in urology for:

  • Treatment of benign prostatic hyperplasia (BPH)
  • Management of lower urinary tract symptoms (LUTS)
  • Control of overactive bladder (OAB) symptoms such as:
    • Urgency
    • Frequency
    • Urge incontinence
  • Improvement of urinary flow and bladder emptying
  • Management of erectile dysfunction (ED) associated with BPH
  • Reduction in prostate size and progression of prostate enlargement
  • Enhancement of overall quality of life in male patients
  • Oral tablet ensures convenient once-daily administration
  • Triple combination improves treatment adherence and clinical outcomes
  • Reduces need for multiple medications (combination therapy in single dose)
  • Stable formulation suitable for long shelf life and export conditions
  • Cost-effective therapy for chronic urology management
  • Available in blister packs and bulk export packaging formats
  • Ideal for private label pharmaceutical brands and international distributors

whatsapp-app